Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/1
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai)
Description: Subject matter under Class 424 definition which contains a designated organic active ingredient, e.g., coal tar, coal tar oil, etc.










Sub-classes under this class:

Class Number Class Name Patents
514/ Heterocyclic carbon cpmpounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai 0
514/149 Azoxy doai 54
514/150 Acyclic nitrogen double bonded to acyclic nitrogen, acyclic nitrogen triple bonded to acyclic nitrogen or azide doai 288
514/152 3,10-dihydroxy-2-naphthacene carboxamide or derivative (e.g., tetracycline, etc.) doai 329
514/155 Para-n-benzene - sulfoxy-n containing doai, and said benzene ring is not part of a polycyclo ring system 77
514/159 Ortho-hydroxybenzoic acid (i.e., salicyclic acid) or derivative doai 380
514/167 9,10-seco- cyclopentanohydrophenanthrene ring system (e.g., vitamin d, etc.) doai 707
514/169 Cyclopentanohydrophenanthrene ring system doai 611
514/183 Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai 2,142
514/2 Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai 7,690
514/22 Lignin or derivative doai 51
514/23 Carbohydrate (i.e., saccharide radical containing) doai 1,811
514/476 N-c(=x)x containing (x is chalcogen) doai 179
514/492 Heavy metal containing doai 681
514/506 Ester doai 329
514/553 Radical -xh acid, or anhydride, acid halide or salt thereof (x is chalcogen) doai 295
514/579 Nitrogen containing other than solely as a nitrogen in an inorganic ion of an addition salt, a nitro or a nitroso doai 301
514/63 Silicon containing doai 1,033
514/64 Boron containing doai 255
514/65 Pyrethrum plant derived material or plant derived rotenone compound containing doai 96
514/675 Ketone doai 216
514/693 Aldehyde doai 172
514/706 Sulfur, selenium or tellurium compound (e.g., thioalcohols, mercaptans, etc.) 247
514/714 Peroxide doai 141
514/715 Ether doai 140
514/724 C-o-group (e.g., alcohol, alcoholate, etc.) doai 587
514/740 Nitrogen containing compound doai 149
514/743 Halogenated hydrocarbon doai 80
514/75 Phosphorus containing other than solely as part of an inorganic ion in an addition salt doai 320
514/762 Hydrocarbon doai 190


Patents under this class:
1 2 3 4 5 6 7 8 9 10 11 12 13 14

Patent Number Title Of Patent Date Issued
8703143 Antibodies of the ED-B domain of fibronectin, their construction and uses Apr. 22, 2014
8691518 Systems and methods for predicting response to minoxidil for the treatment of androgenetic alopecia Apr. 8, 2014
8691747 Method of treatment based on ATAD2 inhibitors Apr. 8, 2014
8685368 Polyamides for nucleic acid delivery Apr. 1, 2014
8685640 Medical methods and agents for use therein Apr. 1, 2014
8685660 Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma Apr. 1, 2014
8685929 Detecting CYP24 expression level as a marker for predisposition to cancer Apr. 1, 2014
8680042 Methods of treating sickle cell anemia-related conditions with MK-801 or memantine Mar. 25, 2014
8680041 Genetic variations associated with tumors Mar. 25, 2014
8679540 Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications Mar. 25, 2014
8673293 Use of modified cells for the treatment of multiple sclerosis Mar. 18, 2014
8673839 Lactoferrin complex and method of producing the same Mar. 18, 2014
8663651 T-140 peptide analogs having CXCR4 super-agonist activity for immunomodulation Mar. 4, 2014
8658602 Multimeric constructs Feb. 25, 2014
8653021 Targeting PAX2 for the treatment of breast cancer Feb. 18, 2014
8653020 Selective exosite inhibition of PAPP-A activity against IGFBP-4 Feb. 18, 2014
8648047 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers Feb. 11, 2014
8637447 Viral capsid proteins and any peptides or compositions thereof for the treatment of pathologic disorders Jan. 28, 2014
8633149 Targeting PAX2 for the treatment of breast cancer Jan. 21, 2014
8628921 Methods for testing milk Jan. 14, 2014
8629117 Method for stimulating the immune system Jan. 14, 2014
8629124 Dextran functionalized by hydrophobic amino acids Jan. 14, 2014
8623810 Protease for wound conditioning and skin care Jan. 7, 2014
8623648 Treatment of pluripotent cells Jan. 7, 2014
8623397 Delivery device and method for forming the same Jan. 7, 2014
8617894 Anti-TNF alpha fibronectin type III domain based scaffold compositions, methods and uses Dec. 31, 2013
8618042 Binding molecules and methods of use thereof Dec. 31, 2013
8613905 Diagnostic agent Dec. 24, 2013
8614192 Method for treating ocular cancer Dec. 24, 2013
8609043 Use of a container of an inorganic additive containing plastic material Dec. 17, 2013
8603964 Methods for modulating angiogenesis via dystrophin Dp71 Dec. 10, 2013
8597640 Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging Dec. 3, 2013
8597902 Peptide protection against ultraviolet light toxicity Dec. 3, 2013
8592362 Method to predict response to pharmacological chaperone treatment of diseases Nov. 26, 2013
8592363 .psi..epsilon.rack peptide composition and method for protection against tissue damage due to ischemia Nov. 26, 2013
8592390 Immunostimulatory method Nov. 26, 2013
8580730 Methods of treating lesional vestibular disorders by administering serotonin 5-HT3 receptor antagonists Nov. 12, 2013
8569225 Targeting complement factor H for treatment of diseases Oct. 29, 2013
8569257 Method for modulating responsiveness to steroids Oct. 29, 2013
8563500 Methods and compounds for treating diseases caused by reactive oxygen species Oct. 22, 2013
8563323 Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disease in hematologic malignan Oct. 22, 2013
8563501 Material for facilitating thermal treatments of biological tissues and method of energy targeting leading to thermal treatment of biological tissues Oct. 22, 2013
8557519 Proteins for use in human and animal Staphyococcus infections Oct. 15, 2013
8557762 Snake factor V and methods of use thereof as a procoagulant Oct. 15, 2013
8551936 Defensin-antigen fusion proteins Oct. 8, 2013
8546319 Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes Oct. 1, 2013
8546320 Hsp9O-targeted anti-cancer chimeric peptide Oct. 1, 2013
8541390 Treatment of cancer by inhibition of IGFBPs and clusterin Sep. 24, 2013
8535258 Hemofiltration methods for treatment of diseases in a mammal Sep. 17, 2013
8536118 Methods and compositions for modulating hyperstabilized c-met Sep. 17, 2013

1 2 3 4 5 6 7 8 9 10 11 12 13 14










 
 
  Recently Added Patents
Rechargeable battery
Can seam inspection
Mobile device mode control based on dual mapping of availability (presence) information
Method and system for remotely testing a wireless device
MRAM with sidewall protection and method of fabrication
Bipolar junction transistor with a self-aligned emitter and base
Method and system for testing indirect bandgap semiconductor devices using luminescence imaging
  Randomly Featured Patents
Fixing structure for components of a cooking appliance
Engine starter
Vertical-axis wind turbine and method for the production thereof
Flame detector and a method
Computer-aided detection of regions of interest in tomographic breast imagery
Chrominance subcarrier generating circuit
Apparatus for preparing an eyeglass lens having a controller for initiation of lens curing
Security bag
Polyphenylene ether/polyamide molding materials
Drive apparatus for a cross coil type meter